Protara Therapeutics Income Statement (2014-2015) | TARA

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015
Revenue & cost
Revenue -0.83M-0.03M2.90M-0.01M
Operating items
Research & Development 1.19M1.60M1.77M1.87M
Selling, General & Administrative 0.74M0.91M1.04M1.40M
Operating Expenses 1.93M2.51M2.81M3.27M
Operating Income -1.93M-2.51M0.13M-3.27M
EBIT -1.93M-2.51M0.13M-3.27M
Non-operating items
Interest & Investment Income 0.01M
Other Non Operating Income -0.07M-0.03M-5.33M10.49M
Non Operating Income -0.90M-0.06M-5.33M11.34M
Net income details
EBT -2.76M-2.54M0.15M-3.29M
Profit After Tax -2.83M-2.56M-5.18M7.23M
Income from Continuing Operations -2.76M-2.54M0.15M-3.29M
Consolidated Net Income -2.76M-2.54M0.15M-3.29M
Income towards Parent Company -2.76M-2.54M0.15M-3.29M
Preferred Dividend Payments 1.51M1.90M-2.28M12.04M
Net Income towards Common Stockholders -4.34M-4.46M-7.46M5.94M
Additional items
EPS (Basic) -18.09-18.55-31.0064.49
Shares Outstanding (Weighted Average) 0.35M0.41M0.41M0.41M0.41M0.41M
EBITDA -1.93M-2.83M-5.17M7.24M
Interest Expenses 0.83M0.03M-0.01M0.01M